Rein Therapeutics Inc (RNTX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access RNTX Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Rein Therapeutics Inc balances growth, leverage, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent43.63
Cash & Short-term Investments43.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.81
Total Current Assets41.45
Equipment/Property/Plant Net0.00
Goodwill net6.33
Intangible Assets13.50
Long-term investments2.98
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent0.00
Total Assets65.97
Liabilities
Accounts Payable, Current AC4.47
Accrued Liabilities And Other Liabilities0.53
Notes Payable, Current NO0.00
Other Liabilities, Current4.72
Total Current Liabilities9.71
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent1.06
DeferredIncomeTaxLiabilitiesNet1.06
Total Liabilities10.77
Stockholders' Equity
Common Stock Value0.17
Additional Paid In Capital Common Stock423.58
Retained Earnings / Accumulated Deficit-413.48
Accumulated Other Comprehensive Income-0.07
Other Equity-0.07
Common Stockholder's Equity10.20
Non-controlling interests & other45.01
Total Stockholder's Equity55.20
Liabilities & Stockholder's Equity65.97
4 historic quarters locked

Sign in to unlock the full Rein Therapeutics Inc balance sheet history.

About Rein Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-350270

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.